Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

× No keyword cloud information.

27 in total

Review 1. Parkinson's disease and levodopa. A five-year follow-up and review.

Authors: C H Markham; L J Treciokas; S G Diamond
Journal: West J Med Date: 1974-09

2. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors: N Callagham; M Mcllroy; M O'Connor
Journal: Ir J Med Sci Date: 1974-03 Impact factor: 1.568

Review 3. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1971 Impact factor: 9.546

4. Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors: U K Rinne; V Sonninen; T Sirtola
Journal: Z Neurol Date: 1972

5. [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors: W Gehlen
Journal: Arch Psychiatr Nervenkr (1970) Date: 1974-04-09

6. Incidence of side effects from levodopa during the introduction of treatment.

Authors: R B Godwin-Austen; C C Frears; S Bergmann
Journal: Br Med J Date: 1971-01-30

7. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.

Authors: R B Godwin-Austen; S Bergmann; C C Frears
Journal: Br Med J Date: 1971-11-27

8. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Authors: Feifei Wang; Takao Yasuhara; Tetsuro Shingo; Masahiro Kameda; Naoki Tajiri; Wen Ji Yuan; Akihiko Kondo; Tomohito Kadota; Tanefumi Baba; Judith Thomas Tayra; Yoichiro Kikuchi; Yasuyuki Miyoshi; Isao Date
Journal: BMC Neurosci Date: 2010-04-26 Impact factor: 3.288

9. Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.

Authors: Pedro Barroso-Chinea; Erwan Bezard
Journal: Front Neuroanat Date: 2010-09-14 Impact factor: 3.856

10. Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors: M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal: J Neurol Neurosurg Psychiatry Date: 1973-06 Impact factor: 10.154